Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Gene

GATA3

2 articles · Resources: NCBI Gene, OncoKB

Molecular biology · Bioinfo & AI

Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer

Xia J, Tian J, Cao Y, et al.

NAR cancer

This study investigated the potential of enhancer RNAs (eRNAs) as biomarkers for breast cancer, complementing traditional protein-coding transcripts. By profiling eRNA expression across over 1000 TCGA-BRCA samples and healthy tissues, researchers developed a 10-eRNA signature that effectively stratified patients into high- and low-risk groups, demonstrating independent prognostic value. Furthermore, a 19-eRNA panel was designed for early detection, showing excellent performance on an independent cohort. These tools have been integrated into eRNACare, a publicly accessible web application, highlighting the promising role of eRNAs for breast cancer risk stratification, therapeutic guidance, and early diagnosis.

Molecular biology

Sensitive detection of somatic mutations in GC-rich cancer gene promoters

Qi M, Dave PS, Francis N, et al.

NAR cancer

Somatic mutations in GC-rich promoter regions are significant drivers of cancer, yet their detection is challenging due to poor sequencing coverage in these areas. This study introduces a hybrid capture assay optimized for over 3000 cancer gene promoters, enabling deep sequencing of these complex regions. This method facilitates the discovery of reliable point mutations, short insertions/deletions, copy number variants, and mutational signatures. The assay nominated candidate noncoding driver mutations in CDK4, SMAD3, and GATA3 in breast cancer, paving the way for future functional follow-up.